Page 481 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 481

Fluid, Electrolyte, and Acid-Base Disturbances in Liver Disease  469


              These hemodynamic maladjustments are mediated by  respectively. Conivaptan has been shown to correct
            the renin-angiotensin-aldosterone system (RAAS) and  hyponatremia in euvolemic or hypervolemic patients. 9
            SNS in response to underfilling of the systemic arterial
            circulation and decreased renal perfusion. 25,86  Abnormal  Increased Basal Cortisol and ACTH Concentrations
            intrarenal accumulation of angiotensin II occurs early in  Increased basal cortisol and adrenocorticotropic hor-
            the disease process, even before activation of the  mone (ACTH) concentrations complicate hepatic insuf-
            RAAS. 125  Renal sodium conservation may be related in  ficiency  associated  with  acquired  portosystemic
            part to enhanced sensitivity to aldosterone.        shunting in dogs, but normal adrenal response to low-
                                                                dose dexamethasone suppression is maintained. 180  High
            Effect of Portosystemic Shunting on Sodium          basal cortisol concentrations also were found in dogs with
            and Water Retention                                 congenital PSVA, and concentrations normalized after
            Portosystemic shunting also may affect sodium and water  successful shunt ligation. 203  In another report, baseline
            retention, and surgically created portosystemic shunts in  cortisol concentrations in dogs with congenital PSVA
            experimental dogs have been used to study the effects of  and in healthy dogs undergoing ovariohysterectomy were
            diverted hepatoportal perfusion on sodium and water  similar. Response to ACTH did not correlate with post-
            balance. Ten weeks after end-to-side portocaval shunt  operative hypoglycemia or prolonged anesthetic recov-
            formation, plasma volume, systemic blood pressure,  ery, which was previously thought to be due to
            and central venous pressures were maintained, and no  inadequate adrenal respose. 105  Dogs with PSVA also have
            changes in GFR, plasma renin activity, or aldosterone  high free-water flux and an abnormally high GFR that
            concentrations were identified. 124  Some dogs maintained  normalize after shunt ligation. 65  It is unknown if this
            normal sodium balance after ingestion of 150 mEq/day  response relates to abnormal cortisol concentration or
            of sodium, but others developed ascites. 124  These  hemodynamic adjustments. Other potential causes for
            findings indicate that in some situations portosystemic  hypercortisolemia in dogs with congenital PSVA include
            shunting alone can impair ability to adapt to increased  decreased hepatic synthesis of cortisol binding proteins,
            sodium loads. This finding may explain the tendency to  decreased hepatic clearance of cortisol, peripheral resis-
            form ascites in some dogs with PSVA (especially those  tance to cortisol, or stress associated with chronic
            with ductus venosus) and hypoalbuminemia or after   nonadrenal illness. 105
            administration of sodium-rich crystalloids.
                                                                Altered Steroid Hormone Metabolism
            Specific Mechanisms of Water and                    Altered steroid hormone metabolism also may contribute
            Electrolyte Disturbances in Cirrhosis               to sodium retention in cirrhosis. Abnormally increased
            and Portosystemic Shunting                          serum bile salt concentrations may inhibit 11b-
            Nonosmotic Vasopressin Stimulation                  hydroxysteroid dehydrogenase-2 (11b-HSD-2), the
            Nonosmotic stimulation of AVP is a central factor   enzyme that interconverts endogenous and exogenous
            mediating water retention in cirrhosis. 90  Acute changes  biologically active 11b-hydroxysteroids and their inactive
            in portal venous pressure in cirrhotic dogs initiate AVP-  11-ketosteroid counterparts. 11b-HSD-2 selectively
            mediated antidiuresis. Both systemic and splanchnic arte-  modulates access of aldosterone to mineralocorticoid
            rial vasodilatation can stimulate nonosmotic AVP release  receptors and normally is located in mineralocorticoid-
            and  activate  other  antidiuretic  and  vasopressor  responsive tissues (including the distal nephron).
            systems. 86,90  Early in cirrhosis (“compensated cirrho-  Absence or inhibition of 11b-HSD-2 can mimic mineral-
            sis”), transient neurohormonal responses increase plasma  ocorticoid excess by allowing inappropriate access of 11b-
            volume and temporarily suppress baroreceptor signaling.  hydroxyglucocorticoids  to  mineralocorticoid
                                                                         4,114,171
            As the disease progresses, arterial vasodilatation worsens,  receptors.  The up-regulation of the vasopressin-
            and neurohormonal responses are no longer able to com-  regulated water channel aquaporin-2 (AQP2) and
            pensate. At this point, vasoconstrictor systems become  increased targeting of AQP2 to luminal membranes likely
            continuously stimulated and promote the sodium and  to contribute to the increased water reabsorption and uri-
            water retention that causes edema and ascites. The  nary concentration in hepatic cirrhosis. 114
            response is exaggerated by abnormal retention of AVP
            as a result of impaired metabolism. Normally, the kidney  Abnormal Aldosterone Release and Responsiveness
            and liver metabolize AVP, but decreased AVP clearance in  to Aldosterone
            hepatic disease correlates with disease severity. 200  High  (or  inappropriately  normal)  aldosterone
            Conivaptan, a nonpeptide, dual V1a/V2 AVP receptor  concentrations precede and accompany pathologic
            antagonist has shown promising results in both      sodium retention in humans and animals with cirrhosis.
            animals 240  and humans. 9  It binds competitively and  Experimentally, hepatic venous congestion and acute por-
            reversibly with high affinity to the V1a and V2 receptors  tal hypertension stimulate aldosterone secretion. 23  The
            that mediate vasoconstriction and water permeability,  importance of aldosterone in sodium and water retention
   476   477   478   479   480   481   482   483   484   485   486